C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2011
10/27/2011	US20110262892 Methods for detection or measurement of viruses
10/27/2011	US20110262626 Antibody Protective Agent And Methods Of Using Same
10/27/2011	US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/27/2011	US20110262476 Mutant bacterial glycoproteins and uses thereof
10/27/2011	US20110262475 Lyme disease vaccine
10/27/2011	US20110262474 Chimeric HIV Antigens
10/27/2011	US20110262463 Syngr4 for target genes of cancer therapy and diagnosis
10/27/2011	US20110262461 Biological materials and uses thereof
10/27/2011	US20110262460 Blood-brain barrier targeting antibodies
10/27/2011	US20110262454 Novel anti-cd38 antibodies for the treatment of cancer
10/27/2011	US20110262452 Anti-hepsin antibodies and methods using same
10/27/2011	US20110262451 Modulators of isovaleryl-coenzyme a dehydrogenase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011	US20110262450 Modulators of monoglyceride lipase in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea
10/27/2011	US20110262449 Method for the treatment of gout or pseudogout
10/27/2011	US20110262448 Human antibodies that bind mesothelin, and uses thereof
10/27/2011	US20110262447 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses
10/27/2011	US20110262445 Anti-il-12/il-23 antibodies
10/27/2011	US20110262443 Epitopes Of Il-17a And Il-17f And Antibodies Specific Thereto
10/27/2011	US20110262441 Method for selective control of helper t cell function
10/27/2011	US20110262440 Treatment of pediatric acute lymphoblastic leukemia
10/27/2011	US20110262439 Bispecific single chain antibodies with specificity for high molecular weight target antigens
10/27/2011	US20110262438 Biological materials related to cxcr7
10/27/2011	US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs
10/27/2011	US20110262430 Novel antibodies
10/27/2011	US20110262429 Human timp-1 antibodies
10/27/2011	US20110262427 Amino acid sequences that modulate the interaction between cells of the immune system
10/27/2011	US20110262390 Composition and method for treating inflammatory disorders
10/27/2011	US20110262361 effective new drug target for the treatment of tuberculosis
10/27/2011	US20110262358 Molecular marker for cancer stem cell
10/27/2011	US20110262353 Muteins of hngal and related proteins with affinity for a given target
10/27/2011	US20110262349 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma
10/27/2011	US20110262348 Selective targeting of intratumoral cells
10/27/2011	US20110262325 Hazardous substance removing material and a method for removing hazardous substance
10/27/2011	DE102010018085A1 Verfahren zur Erkennung einer Salmonelleninfektion A method for detecting Salmonella infection
10/27/2011	CA2796633A1 Production of heteromultimeric proteins
10/27/2011	CA2789071A1 Antibodies against human csf-1r and uses thereof
10/26/2011	EP2381256A1 Mammalian sweet and amino acid heterodimeric taste receptors
10/26/2011	EP2380976A1 Human anti-human influenza virus antibody
10/26/2011	EP2380913A1 Novel anti-IGF-IR antibodies and uses thereof
10/26/2011	EP2380912A1 Novel anti-IGF-IR antibodies and uses thereof
10/26/2011	EP2380911A1 Antigen binding molecules with increased Fc receptor binding affinity and effector function
10/26/2011	EP2380910A1 Antigen binding molecules with increased Fc receptor binding affinity and effector function
10/26/2011	EP2380909A1 PTK-7 protein involved in breast cancer
10/26/2011	EP2380908A1 Hepatocyte growth factor (hgf) binding proteins
10/26/2011	EP2380907A1 Methods and compositions for the treatment of antibody mediated neuropathies
10/26/2011	EP2380906A2 Artificial antibody polypeptides
10/26/2011	EP2380903A1 Differential in tumour gene products and use of same
10/26/2011	EP2380592A2 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
10/26/2011	EP2380588A1 Therapeutic Vaccine
10/26/2011	EP2380585A1 Methods of treating autoimmune diseases
10/26/2011	EP2379727A1 Non-human transgenic animals expressing humanised antibodies and use therof
10/26/2011	EP2379601A1 Anti-idiotype antibody against an antibody against the amyloid peptide
10/26/2011	EP2379600A1 Antibodies against tissue factor pathway inhibitor
10/26/2011	EP2379599A1 Antibodies against tissue factor pathway inhibitor (tfpi)
10/26/2011	EP2379598A1 Anti-kir3d antibodies
10/26/2011	EP2379597A2 Egfr-homing double-stranded rna vector for systemic cancer treatment
10/26/2011	EP2379596A1 Targeted binding agents directed to 5 1 and uses therefor
10/26/2011	EP2379595A2 Targeted binding agents directed to 5 1 and uses thereof
10/26/2011	EP2379594A1 Human cgrp receptor binding proteins
10/26/2011	EP2379593A2 Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders
10/26/2011	EP2379592A1 Antibodies against human angiopoietin 2
10/26/2011	EP2379591A1 Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza a viruses and uses thereof
10/26/2011	EP2379590A1 Anti-herpes simplex virus antibodies and methods of use thereof
10/26/2011	EP2379588A2 The use of basigin-1 in stem cell and cancer applications
10/26/2011	EP2379116A2 Antigens associated with endometriosis, psoriatic arthritis and psoriasis
10/26/2011	EP2379109A1 Combination of photodynamic therapy and anti-vegf agents in the treatment of unwanted choroidal neovasculature
10/26/2011	EP2379108A1 Immunoglobulin purification
10/26/2011	EP2046835B1 Antibodies to il-17a
10/26/2011	EP1996626B1 Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
10/26/2011	EP1912674B1 Bispecific single chain fv antibody molecules and methods of use thereof
10/26/2011	EP1729806B1 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
10/26/2011	EP1575509B1 Epha2 agonistic monoclonal antibodies and methods of use thereof
10/26/2011	EP1469310B1 Diagnostic for scleroderma
10/26/2011	EP1352055B1 Map kinase integrin-binding domain
10/26/2011	EP1060247B2 Ox-40 receptor binding agent for use in methods for enhancing tumour antigen-specific immune response
10/26/2011	EP0787191B2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
10/26/2011	CN102227447A Cd86 antagonist multi-target binding proteins
10/26/2011	CN102227446A Anti-cmet antibody
10/26/2011	CN102227445A Antibody capable of binding to envelope protein 2 of hepatitis c virus, and method for identifying genotype of hepatitis c virus using same
10/26/2011	CN102227226A Anti-igf antibodies
10/26/2011	CN102226171A Diagnostic kit containing anti-dog hemoglobin monoclonal antibody and application thereof
10/26/2011	CN102226153A Preparation method of immunogen for generating infectious microbe antiserum
10/26/2011	CN101899112B Light chain and heavy chain variable region of FMU-EPCAM-2D7 monoclonal antibody
10/26/2011	CN101851291B Heavy chain and light chain variable regions of anti-human BAFF monoclonal antibody
10/26/2011	CN101817882B Light-chain variable region and heavy-chain variable region of FMU-EPCAM-4E4 monoclonal antibody
10/26/2011	CN101735319B Monoclonal antibody against GP73 protein, preparation method and application thereof
10/26/2011	CN101701039B Variable regions of light chains and heavy chains of FMU-EPCAM-2A9 monoclonal antibodies
10/26/2011	CN101591390B H5N1 derived avian influenza virus NP resistant monoclonal antibody and application thereof
10/26/2011	CN101585880B Variable regions on heavy and light chains of antihuman IL-13R alpha 2 monoclonal antibodies
10/26/2011	CN101168562B CBP C end protein, monoclonal antibody thereof, preparation and use of the same
10/25/2011	US8044259 Determining the capability of a test compound to affect solid tumor stem cells
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044181 Antibodies to the PcrV antigen of Pseudomonas aeruginosa
10/25/2011	US8044180 FcγRIIB specific antibodies and methods of use thereof
10/25/2011	US8044179 Methods and compositions for modulating tumor cell activity
10/25/2011	US8044178 Anti-5T4 antibodies and uses thereof
10/25/2011	US8044025 Urocortin proteins and uses thereof
10/25/2011	US8044022 Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
10/25/2011	US8044017 Ion exchange chromatography; gradient wash; resolution; remove impurities
10/25/2011	US8043852 Monoclonal antibody specific to dentin-derived heparan sulfate

1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 1494